CoreFi Strategy, an upcoming publicly traded company, aims to simulate MicroStrategy's success in Bitcoin, but this time, ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

DeFi Technologies has announced plans to launch CoreFi Strategy, a new investment vehicle aimed at providing exposure to ...

DeFi Technologies has unveiled a new CoreFi Strategy that will offer investors a means to bet on Bitcoin in decentralized ...

DeFi Technologies launches CoreFi Strategy, offering regulated, leveraged Bitcoin yields through Core blockchain's BTCfi ...